1 active not recruiting, 1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Active not recruiting 1 |
Follow House Ear Institute: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease Montelukast, Placebo - Meniere Disease, Allergic Rhinitis | Phase 4 | Active not recruiting | House Ear Institute | 39 | 2021-06-07 | 2025-03-18 |
| NF2 Natural History Consortium Schwannoma, Vestibular, Neurofibromatosis 2 | Unknown | House Ear Institute | 100 | 2002-01-01 | 2005-09-29 |
Meniere Disease (1) · Meningioma (1) · Neurofibromatosis 2 (1) · Neuroma, Acoustic (1) · Rhinitis, Allergic (1) · Vertigo (1)
montelukast (1)
United States (2)
Mary J Derebery, MD (1) · William H. Slattery, III (1)